BioNTech SE Sponsored ADR (NASDAQ:BNTX) Short Interest Down 20.7% in March

robot
Abstract generation in progress

Short interest in BioNTech SE (NASDAQ:BNTX) significantly decreased by 20.7% in March, totaling 3,537,489 shares, which represents about 1.8% of its shares outstanding. This reduction resulted in a short-interest ratio of 1.4 days based on average daily trading volume. Analysts maintain a “Moderate Buy” consensus rating for BioNTech, with a target price of $133.73, while institutional investors have adjusted their holdings in the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin